✦ LIBER ✦

Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours

✍ Scribed by Klaus Mross; Joachim Drevs; Marianne Müller; Michael Medinger; Dieter Marmé; Jürgen Hennig; Bruno Morgan; David Lebwohl; Eric Masson; Yu-Yun Ho; Clemens Günther; Dirk Laurent; Clemens Unger

Book ID: 116428542
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 152 KB
Volume: 41
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2005.03.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers for assessment of pharmacolog

Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases

✍ Lucy Lee; Sunil Sharma; Bruno Morgan; Peter Allegrini; Christian Schnell; Josef 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 427 KB

A phase I dose escalation and pharmacoki

A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors

✍ E. Gabriela Chiorean; Srikar Malireddy; Anne E. Younger; David R. Jones; Mary-Ja 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

1474 POSTER A phase I, open-label study

1474 POSTER A phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Phase I clinical, pharmacokinetic and ph

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

✍ Razak, A R A; Hotte, S J; Siu, L L; Chen, E X; Hirte, H W; Powers, J; Walsh, W; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 308 KB

A phase I clinical and pharmacokinetic s

A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours

✍ Miguel Angel Izquierdo; Margarita García; José Luis Pontón; Marisa Martínez; Vic 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A phase I study of the oral vascular end

A phase I study of the oral vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor PTK787/ZK 222584 on a twice daily schedule in patients with advanced cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 143 KB